SCHEMBL7740293

SCHEMBL7740293

O=c1nc2cc[nH]n2c2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 8/20 0.43
KDM4E B2RXH2 7/20 0.43
HPGD P15428 7/20 0.43
ALDH1A1 P00352 5/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TP53 P04637 2/20 0.43
LOXL2 Q9Y4K0 1/20 0.41
KMT2A Q03164 5/20 0.39
MEN1 O00255 4/20 0.39
RCE1 Q9Y256 1/20 0.39
RAD51 Q06609 1/20 0.38
TSHR P16473 3/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
SMARCA4 P51532 3/20 0.35
PBRM1 Q86U86 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30773025 0.75 KDM4E (0.45) HSD17B10KDM4EHPGDALDH1A1NPC1
SCHEMBL2274843 0.74 ATM (0.40) HSD17B10KDM4EHPGDALDH1A1NPC1
SCHEMBL9462302 0.72 KDM4E (0.51) HSD17B10KDM4EHPGDALDH1A1NPC1
SCHEMBL9598677 0.71 KDM5B (0.48) HSD17B10KDM4EHPGDALDH1A1NPC1
SCHEMBL12883867 0.68 KDM4E (0.54) HSD17B10KDM4EHPGDALDH1A1NPC1
SCHEMBL11779144 0.64 KDM4E (0.39) HSD17B10KDM4EHPGDALDH1A1NPC1
SCHEMBL11642434 0.63 RAD51 (0.73) KDM4EHPGDALDH1A1NPC1RAB9A
SCHEMBL30935910 0.63 PARP1 (0.52) HSD17B10KDM4EHPGDALDH1A1NPC1
SCHEMBL202483 0.62 KDM4E (0.44) KDM4EALDH1A1LOXL2
SCHEMBL2270547 0.62 RAD51 (0.38) KDM4EHPGDALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197897-A1 SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALLOSTERIC MODULATORS OF GROUP IIMETABOTROPIC GLUTAMATE RECEPTORS Domain Therapeutics (FR) 2017-08-02 EP claimed
WO-2016046404-A1 SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALLOSTERIC MODULATORS OF GROUP IIMETABOTROPIC GLUTAMATE RECEPTORS DOMAIN THERAPEUTICS (FR) 2016-03-31 WO claimed
EP-2861597-A1 SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALLOSTERIC MODULATORS OF GROUP II METABOTROPIC GLUTAMATE RECEPTORS Domain Therapeutics (FR) 2015-04-22 EP claimed
WO-2013174822-A1 SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALLOSTERIC MODULATORS OF GROUP II METABOTROPIC GLUTAMATE RECEPTORS DOMAIN THERAPEUTICS (FR) 2013-11-28 WO claimed
CN-117561258-A Novel substituted tricyclic aza heterocycles as SOS1 inhibitors 唯久生物技术(苏州)有限公司 2024-02-13 CN disclosed
EP-3197897-A1 SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALLOSTERIC MODULATORS OF GROUP IIMETABOTROPIC GLUTAMATE RECEPTORS Domain Therapeutics (FR) 2017-08-02 EP disclosed
WO-2016046404-A1 SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALLOSTERIC MODULATORS OF GROUP IIMETABOTROPIC GLUTAMATE RECEPTORS DOMAIN THERAPEUTICS (FR) 2016-03-31 WO disclosed
EP-2861597-A1 SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALLOSTERIC MODULATORS OF GROUP II METABOTROPIC GLUTAMATE RECEPTORS Domain Therapeutics (FR) 2015-04-22 EP disclosed
WO-2013174822-A1 SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALLOSTERIC MODULATORS OF GROUP II METABOTROPIC GLUTAMATE RECEPTORS DOMAIN THERAPEUTICS (FR) 2013-11-28 WO disclosed
US-6365335-B1 SENSITIVITY AND DECREASED IN RESIDUAL COLOR FUJI PHOTO FILM CO., LTD. (JP) 2002-04-02 US disclosed